nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—Alkylating Activity—Altretamine—ovarian cancer	0.391	0.465	CiPCiCtD
Trabectedin—Alkylating Activity—Melphalan—ovarian cancer	0.225	0.267	CiPCiCtD
Trabectedin—Alkylating Activity—Chlorambucil—ovarian cancer	0.225	0.267	CiPCiCtD
Trabectedin—CYP2D6—Vinorelbine—ovarian cancer	0.00721	0.213	CbGbCtD
Trabectedin—CYP3A4—Topotecan—ovarian cancer	0.00651	0.192	CbGbCtD
Trabectedin—CYP2C9—Paclitaxel—ovarian cancer	0.00554	0.164	CbGbCtD
Trabectedin—CYP3A4—Vinorelbine—ovarian cancer	0.00459	0.135	CbGbCtD
Trabectedin—CYP3A4—Paclitaxel—ovarian cancer	0.00322	0.0951	CbGbCtD
Trabectedin—CYP2D6—Doxorubicin—ovarian cancer	0.00273	0.0806	CbGbCtD
Trabectedin—CYP3A4—Docetaxel—ovarian cancer	0.00233	0.0688	CbGbCtD
Trabectedin—CYP3A4—Doxorubicin—ovarian cancer	0.00174	0.0513	CbGbCtD
Trabectedin—PTGS1—oviduct—ovarian cancer	0.000552	0.11	CbGeAlD
Trabectedin—SRC—embryo—ovarian cancer	0.000455	0.0907	CbGeAlD
Trabectedin—SRC—epithelium—ovarian cancer	0.000371	0.074	CbGeAlD
Trabectedin—SRC—uterine cervix—ovarian cancer	0.000368	0.0734	CbGeAlD
Trabectedin—SRC—decidua—ovarian cancer	0.000351	0.0699	CbGeAlD
Trabectedin—SRC—gonad—ovarian cancer	0.000309	0.0615	CbGeAlD
Trabectedin—SRC—female reproductive system—ovarian cancer	0.000276	0.055	CbGeAlD
Trabectedin—SRC—female gonad—ovarian cancer	0.000251	0.05	CbGeAlD
Trabectedin—SRC—testis—ovarian cancer	0.000222	0.0444	CbGeAlD
Trabectedin—SRC—lymph node—ovarian cancer	0.000161	0.0321	CbGeAlD
Trabectedin—PTGS1—epithelium—ovarian cancer	0.000139	0.0276	CbGeAlD
Trabectedin—PTGS1—uterine cervix—ovarian cancer	0.000137	0.0274	CbGeAlD
Trabectedin—CYP2C19—vagina—ovarian cancer	0.000131	0.0262	CbGeAlD
Trabectedin—PTGS1—endometrium—ovarian cancer	0.000124	0.0248	CbGeAlD
Trabectedin—PTGS1—uterus—ovarian cancer	0.000114	0.0228	CbGeAlD
Trabectedin—CYP2C9—female reproductive system—ovarian cancer	0.000113	0.0225	CbGeAlD
Trabectedin—CYP2E1—female reproductive system—ovarian cancer	0.000107	0.0213	CbGeAlD
Trabectedin—PTGS1—female reproductive system—ovarian cancer	0.000103	0.0205	CbGeAlD
Trabectedin—PTGS1—female gonad—ovarian cancer	9.36e-05	0.0187	CbGeAlD
Trabectedin—PTGS1—vagina—ovarian cancer	9.31e-05	0.0186	CbGeAlD
Trabectedin—CYP2E1—testis—ovarian cancer	8.62e-05	0.0172	CbGeAlD
Trabectedin—CYP3A4—female reproductive system—ovarian cancer	8.59e-05	0.0171	CbGeAlD
Trabectedin—CYP2D6—female reproductive system—ovarian cancer	8.46e-05	0.0169	CbGeAlD
Trabectedin—PTGS1—testis—ovarian cancer	8.3e-05	0.0166	CbGeAlD
Trabectedin—Asthenia—Topotecan—ovarian cancer	8.27e-05	0.00104	CcSEcCtD
Trabectedin—Alopecia—Paclitaxel—ovarian cancer	8.25e-05	0.00104	CcSEcCtD
Trabectedin—Vomiting—Chlorambucil—ovarian cancer	8.23e-05	0.00104	CcSEcCtD
Trabectedin—Agranulocytosis—Docetaxel—ovarian cancer	8.23e-05	0.00104	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	8.21e-05	0.00103	CcSEcCtD
Trabectedin—Mental disorder—Paclitaxel—ovarian cancer	8.18e-05	0.00103	CcSEcCtD
Trabectedin—Malnutrition—Paclitaxel—ovarian cancer	8.13e-05	0.00102	CcSEcCtD
Trabectedin—Asthenia—Melphalan—ovarian cancer	8.1e-05	0.00102	CcSEcCtD
Trabectedin—Gastrointestinal pain—Vinorelbine—ovarian cancer	8.06e-05	0.00102	CcSEcCtD
Trabectedin—Dysgeusia—Paclitaxel—ovarian cancer	7.96e-05	0.001	CcSEcCtD
Trabectedin—Haemoglobin—Docetaxel—ovarian cancer	7.95e-05	0.001	CcSEcCtD
Trabectedin—Hepatic failure—Doxorubicin—ovarian cancer	7.94e-05	0.001	CcSEcCtD
Trabectedin—Haemorrhage—Docetaxel—ovarian cancer	7.91e-05	0.000997	CcSEcCtD
Trabectedin—Diarrhoea—Topotecan—ovarian cancer	7.89e-05	0.000994	CcSEcCtD
Trabectedin—Back pain—Paclitaxel—ovarian cancer	7.86e-05	0.00099	CcSEcCtD
Trabectedin—Abdominal pain—Vinorelbine—ovarian cancer	7.8e-05	0.000982	CcSEcCtD
Trabectedin—Body temperature increased—Vinorelbine—ovarian cancer	7.8e-05	0.000982	CcSEcCtD
Trabectedin—Oedema peripheral—Docetaxel—ovarian cancer	7.8e-05	0.000982	CcSEcCtD
Trabectedin—Connective tissue disorder—Docetaxel—ovarian cancer	7.78e-05	0.00098	CcSEcCtD
Trabectedin—Diarrhoea—Melphalan—ovarian cancer	7.72e-05	0.000973	CcSEcCtD
Trabectedin—CYP2D6—female gonad—ovarian cancer	7.7e-05	0.0153	CbGeAlD
Trabectedin—Nausea—Chlorambucil—ovarian cancer	7.69e-05	0.000969	CcSEcCtD
Trabectedin—Dizziness—Topotecan—ovarian cancer	7.62e-05	0.00096	CcSEcCtD
Trabectedin—Anaemia—Paclitaxel—ovarian cancer	7.51e-05	0.000946	CcSEcCtD
Trabectedin—Flushing—Docetaxel—ovarian cancer	7.34e-05	0.000925	CcSEcCtD
Trabectedin—Vomiting—Topotecan—ovarian cancer	7.33e-05	0.000923	CcSEcCtD
Trabectedin—Syncope—Paclitaxel—ovarian cancer	7.29e-05	0.000918	CcSEcCtD
Trabectedin—Leukopenia—Paclitaxel—ovarian cancer	7.28e-05	0.000916	CcSEcCtD
Trabectedin—Rash—Topotecan—ovarian cancer	7.27e-05	0.000916	CcSEcCtD
Trabectedin—Hypersensitivity—Vinorelbine—ovarian cancer	7.27e-05	0.000915	CcSEcCtD
Trabectedin—Dermatitis—Topotecan—ovarian cancer	7.26e-05	0.000915	CcSEcCtD
Trabectedin—Blood creatinine increased—Epirubicin—ovarian cancer	7.23e-05	0.000911	CcSEcCtD
Trabectedin—Headache—Topotecan—ovarian cancer	7.22e-05	0.00091	CcSEcCtD
Trabectedin—Angiopathy—Docetaxel—ovarian cancer	7.18e-05	0.000904	CcSEcCtD
Trabectedin—Vomiting—Melphalan—ovarian cancer	7.18e-05	0.000904	CcSEcCtD
Trabectedin—Dehydration—Epirubicin—ovarian cancer	7.18e-05	0.000904	CcSEcCtD
Trabectedin—Loss of consciousness—Paclitaxel—ovarian cancer	7.14e-05	0.0009	CcSEcCtD
Trabectedin—Mediastinal disorder—Docetaxel—ovarian cancer	7.13e-05	0.000898	CcSEcCtD
Trabectedin—Rash—Melphalan—ovarian cancer	7.12e-05	0.000897	CcSEcCtD
Trabectedin—Dermatitis—Melphalan—ovarian cancer	7.11e-05	0.000896	CcSEcCtD
Trabectedin—Cough—Paclitaxel—ovarian cancer	7.09e-05	0.000893	CcSEcCtD
Trabectedin—Asthenia—Vinorelbine—ovarian cancer	7.08e-05	0.000891	CcSEcCtD
Trabectedin—Abdominal pain upper—Epirubicin—ovarian cancer	7.05e-05	0.000888	CcSEcCtD
Trabectedin—Hypokalaemia—Epirubicin—ovarian cancer	7.02e-05	0.000885	CcSEcCtD
Trabectedin—Alopecia—Docetaxel—ovarian cancer	6.99e-05	0.000881	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	6.95e-05	0.000875	CcSEcCtD
Trabectedin—Mental disorder—Docetaxel—ovarian cancer	6.93e-05	0.000873	CcSEcCtD
Trabectedin—Myalgia—Paclitaxel—ovarian cancer	6.92e-05	0.000872	CcSEcCtD
Trabectedin—Arthralgia—Paclitaxel—ovarian cancer	6.92e-05	0.000872	CcSEcCtD
Trabectedin—Malnutrition—Docetaxel—ovarian cancer	6.89e-05	0.000868	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	6.87e-05	0.000866	CcSEcCtD
Trabectedin—Nausea—Topotecan—ovarian cancer	6.85e-05	0.000863	CcSEcCtD
Trabectedin—CYP2D6—testis—ovarian cancer	6.82e-05	0.0136	CbGeAlD
Trabectedin—Alanine aminotransferase increased—Epirubicin—ovarian cancer	6.81e-05	0.000857	CcSEcCtD
Trabectedin—Diarrhoea—Vinorelbine—ovarian cancer	6.75e-05	0.00085	CcSEcCtD
Trabectedin—Dysgeusia—Docetaxel—ovarian cancer	6.75e-05	0.00085	CcSEcCtD
Trabectedin—Nausea—Melphalan—ovarian cancer	6.71e-05	0.000845	CcSEcCtD
Trabectedin—Blood creatinine increased—Doxorubicin—ovarian cancer	6.69e-05	0.000843	CcSEcCtD
Trabectedin—Back pain—Docetaxel—ovarian cancer	6.66e-05	0.000839	CcSEcCtD
Trabectedin—Dehydration—Doxorubicin—ovarian cancer	6.64e-05	0.000836	CcSEcCtD
Trabectedin—Oedema—Paclitaxel—ovarian cancer	6.63e-05	0.000836	CcSEcCtD
Trabectedin—Infection—Paclitaxel—ovarian cancer	6.59e-05	0.00083	CcSEcCtD
Trabectedin—Shock—Paclitaxel—ovarian cancer	6.53e-05	0.000822	CcSEcCtD
Trabectedin—Dizziness—Vinorelbine—ovarian cancer	6.52e-05	0.000822	CcSEcCtD
Trabectedin—Abdominal pain upper—Doxorubicin—ovarian cancer	6.52e-05	0.000821	CcSEcCtD
Trabectedin—Nervous system disorder—Paclitaxel—ovarian cancer	6.51e-05	0.000819	CcSEcCtD
Trabectedin—Hypokalaemia—Doxorubicin—ovarian cancer	6.5e-05	0.000818	CcSEcCtD
Trabectedin—Thrombocytopenia—Paclitaxel—ovarian cancer	6.49e-05	0.000818	CcSEcCtD
Trabectedin—Skin disorder—Paclitaxel—ovarian cancer	6.44e-05	0.000812	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	6.43e-05	0.00081	CcSEcCtD
Trabectedin—Anaemia—Docetaxel—ovarian cancer	6.37e-05	0.000802	CcSEcCtD
Trabectedin—Pancytopenia—Epirubicin—ovarian cancer	6.33e-05	0.000798	CcSEcCtD
Trabectedin—Anorexia—Paclitaxel—ovarian cancer	6.32e-05	0.000797	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	6.3e-05	0.000793	CcSEcCtD
Trabectedin—Vomiting—Vinorelbine—ovarian cancer	6.27e-05	0.00079	CcSEcCtD
Trabectedin—Neutropenia—Epirubicin—ovarian cancer	6.24e-05	0.000786	CcSEcCtD
Trabectedin—Rash—Vinorelbine—ovarian cancer	6.22e-05	0.000783	CcSEcCtD
Trabectedin—Dermatitis—Vinorelbine—ovarian cancer	6.21e-05	0.000783	CcSEcCtD
Trabectedin—Hypotension—Paclitaxel—ovarian cancer	6.2e-05	0.000781	CcSEcCtD
Trabectedin—Headache—Vinorelbine—ovarian cancer	6.18e-05	0.000778	CcSEcCtD
Trabectedin—Syncope—Docetaxel—ovarian cancer	6.18e-05	0.000778	CcSEcCtD
Trabectedin—Leukopenia—Docetaxel—ovarian cancer	6.17e-05	0.000777	CcSEcCtD
Trabectedin—Loss of consciousness—Docetaxel—ovarian cancer	6.05e-05	0.000763	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	6.04e-05	0.000761	CcSEcCtD
Trabectedin—Weight decreased—Epirubicin—ovarian cancer	6.03e-05	0.00076	CcSEcCtD
Trabectedin—PTGS1—lymph node—ovarian cancer	6.02e-05	0.012	CbGeAlD
Trabectedin—Cough—Docetaxel—ovarian cancer	6.01e-05	0.000757	CcSEcCtD
Trabectedin—Insomnia—Paclitaxel—ovarian cancer	6e-05	0.000756	CcSEcCtD
Trabectedin—Paraesthesia—Paclitaxel—ovarian cancer	5.96e-05	0.00075	CcSEcCtD
Trabectedin—Infestation NOS—Epirubicin—ovarian cancer	5.95e-05	0.000749	CcSEcCtD
Trabectedin—Infestation—Epirubicin—ovarian cancer	5.95e-05	0.000749	CcSEcCtD
Trabectedin—Dyspnoea—Paclitaxel—ovarian cancer	5.91e-05	0.000745	CcSEcCtD
Trabectedin—Arthralgia—Docetaxel—ovarian cancer	5.87e-05	0.000739	CcSEcCtD
Trabectedin—Myalgia—Docetaxel—ovarian cancer	5.87e-05	0.000739	CcSEcCtD
Trabectedin—Pancytopenia—Doxorubicin—ovarian cancer	5.86e-05	0.000738	CcSEcCtD
Trabectedin—Nausea—Vinorelbine—ovarian cancer	5.86e-05	0.000738	CcSEcCtD
Trabectedin—Dyspepsia—Paclitaxel—ovarian cancer	5.84e-05	0.000736	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	5.82e-05	0.000734	CcSEcCtD
Trabectedin—Stomatitis—Epirubicin—ovarian cancer	5.8e-05	0.00073	CcSEcCtD
Trabectedin—Jaundice—Epirubicin—ovarian cancer	5.8e-05	0.00073	CcSEcCtD
Trabectedin—Neutropenia—Doxorubicin—ovarian cancer	5.77e-05	0.000727	CcSEcCtD
Trabectedin—Decreased appetite—Paclitaxel—ovarian cancer	5.77e-05	0.000726	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	5.73e-05	0.000721	CcSEcCtD
Trabectedin—Fatigue—Paclitaxel—ovarian cancer	5.72e-05	0.00072	CcSEcCtD
Trabectedin—Constipation—Paclitaxel—ovarian cancer	5.67e-05	0.000715	CcSEcCtD
Trabectedin—Hepatobiliary disease—Epirubicin—ovarian cancer	5.62e-05	0.000708	CcSEcCtD
Trabectedin—Oedema—Docetaxel—ovarian cancer	5.62e-05	0.000708	CcSEcCtD
Trabectedin—Infection—Docetaxel—ovarian cancer	5.59e-05	0.000704	CcSEcCtD
Trabectedin—Weight decreased—Doxorubicin—ovarian cancer	5.58e-05	0.000703	CcSEcCtD
Trabectedin—Agranulocytosis—Epirubicin—ovarian cancer	5.55e-05	0.000699	CcSEcCtD
Trabectedin—Shock—Docetaxel—ovarian cancer	5.53e-05	0.000697	CcSEcCtD
Trabectedin—Nervous system disorder—Docetaxel—ovarian cancer	5.51e-05	0.000695	CcSEcCtD
Trabectedin—Thrombocytopenia—Docetaxel—ovarian cancer	5.5e-05	0.000693	CcSEcCtD
Trabectedin—Infestation NOS—Doxorubicin—ovarian cancer	5.5e-05	0.000693	CcSEcCtD
Trabectedin—Infestation—Doxorubicin—ovarian cancer	5.5e-05	0.000693	CcSEcCtD
Trabectedin—Skin disorder—Docetaxel—ovarian cancer	5.46e-05	0.000688	CcSEcCtD
Trabectedin—Gastrointestinal pain—Paclitaxel—ovarian cancer	5.42e-05	0.000683	CcSEcCtD
Trabectedin—Haemoglobin—Epirubicin—ovarian cancer	5.36e-05	0.000676	CcSEcCtD
Trabectedin—Stomatitis—Doxorubicin—ovarian cancer	5.36e-05	0.000676	CcSEcCtD
Trabectedin—Jaundice—Doxorubicin—ovarian cancer	5.36e-05	0.000676	CcSEcCtD
Trabectedin—Anorexia—Docetaxel—ovarian cancer	5.36e-05	0.000675	CcSEcCtD
Trabectedin—Haemorrhage—Epirubicin—ovarian cancer	5.34e-05	0.000672	CcSEcCtD
Trabectedin—Oedema peripheral—Epirubicin—ovarian cancer	5.26e-05	0.000662	CcSEcCtD
Trabectedin—Hypotension—Docetaxel—ovarian cancer	5.25e-05	0.000662	CcSEcCtD
Trabectedin—Connective tissue disorder—Epirubicin—ovarian cancer	5.25e-05	0.000661	CcSEcCtD
Trabectedin—Abdominal pain—Paclitaxel—ovarian cancer	5.24e-05	0.000661	CcSEcCtD
Trabectedin—Body temperature increased—Paclitaxel—ovarian cancer	5.24e-05	0.000661	CcSEcCtD
Trabectedin—Hepatobiliary disease—Doxorubicin—ovarian cancer	5.2e-05	0.000655	CcSEcCtD
Trabectedin—Agranulocytosis—Doxorubicin—ovarian cancer	5.13e-05	0.000647	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	5.12e-05	0.000645	CcSEcCtD
Trabectedin—Insomnia—Docetaxel—ovarian cancer	5.09e-05	0.000641	CcSEcCtD
Trabectedin—Paraesthesia—Docetaxel—ovarian cancer	5.05e-05	0.000636	CcSEcCtD
Trabectedin—Dyspnoea—Docetaxel—ovarian cancer	5.01e-05	0.000631	CcSEcCtD
Trabectedin—Haemoglobin—Doxorubicin—ovarian cancer	4.96e-05	0.000625	CcSEcCtD
Trabectedin—Flushing—Epirubicin—ovarian cancer	4.95e-05	0.000624	CcSEcCtD
Trabectedin—Dyspepsia—Docetaxel—ovarian cancer	4.95e-05	0.000623	CcSEcCtD
Trabectedin—Haemorrhage—Doxorubicin—ovarian cancer	4.94e-05	0.000622	CcSEcCtD
Trabectedin—Decreased appetite—Docetaxel—ovarian cancer	4.89e-05	0.000616	CcSEcCtD
Trabectedin—Hypersensitivity—Paclitaxel—ovarian cancer	4.89e-05	0.000616	CcSEcCtD
Trabectedin—Oedema peripheral—Doxorubicin—ovarian cancer	4.87e-05	0.000613	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Docetaxel—ovarian cancer	4.85e-05	0.000611	CcSEcCtD
Trabectedin—Connective tissue disorder—Doxorubicin—ovarian cancer	4.85e-05	0.000611	CcSEcCtD
Trabectedin—Fatigue—Docetaxel—ovarian cancer	4.85e-05	0.000611	CcSEcCtD
Trabectedin—Angiopathy—Epirubicin—ovarian cancer	4.84e-05	0.00061	CcSEcCtD
Trabectedin—Mediastinal disorder—Epirubicin—ovarian cancer	4.81e-05	0.000606	CcSEcCtD
Trabectedin—Constipation—Docetaxel—ovarian cancer	4.81e-05	0.000606	CcSEcCtD
Trabectedin—Asthenia—Paclitaxel—ovarian cancer	4.76e-05	0.0006	CcSEcCtD
Trabectedin—Alopecia—Epirubicin—ovarian cancer	4.72e-05	0.000594	CcSEcCtD
Trabectedin—Mental disorder—Epirubicin—ovarian cancer	4.68e-05	0.000589	CcSEcCtD
Trabectedin—Malnutrition—Epirubicin—ovarian cancer	4.65e-05	0.000585	CcSEcCtD
Trabectedin—Gastrointestinal pain—Docetaxel—ovarian cancer	4.6e-05	0.000579	CcSEcCtD
Trabectedin—Flushing—Doxorubicin—ovarian cancer	4.58e-05	0.000577	CcSEcCtD
Trabectedin—Dysgeusia—Epirubicin—ovarian cancer	4.55e-05	0.000573	CcSEcCtD
Trabectedin—Diarrhoea—Paclitaxel—ovarian cancer	4.54e-05	0.000572	CcSEcCtD
Trabectedin—Back pain—Epirubicin—ovarian cancer	4.49e-05	0.000566	CcSEcCtD
Trabectedin—Angiopathy—Doxorubicin—ovarian cancer	4.48e-05	0.000564	CcSEcCtD
Trabectedin—Mediastinal disorder—Doxorubicin—ovarian cancer	4.45e-05	0.000561	CcSEcCtD
Trabectedin—Abdominal pain—Docetaxel—ovarian cancer	4.44e-05	0.00056	CcSEcCtD
Trabectedin—Body temperature increased—Docetaxel—ovarian cancer	4.44e-05	0.00056	CcSEcCtD
Trabectedin—Dizziness—Paclitaxel—ovarian cancer	4.39e-05	0.000553	CcSEcCtD
Trabectedin—Alopecia—Doxorubicin—ovarian cancer	4.36e-05	0.00055	CcSEcCtD
Trabectedin—Mental disorder—Doxorubicin—ovarian cancer	4.33e-05	0.000545	CcSEcCtD
Trabectedin—Malnutrition—Doxorubicin—ovarian cancer	4.3e-05	0.000542	CcSEcCtD
Trabectedin—Anaemia—Epirubicin—ovarian cancer	4.29e-05	0.000541	CcSEcCtD
Trabectedin—Vomiting—Paclitaxel—ovarian cancer	4.22e-05	0.000531	CcSEcCtD
Trabectedin—Dysgeusia—Doxorubicin—ovarian cancer	4.21e-05	0.00053	CcSEcCtD
Trabectedin—Rash—Paclitaxel—ovarian cancer	4.18e-05	0.000527	CcSEcCtD
Trabectedin—Dermatitis—Paclitaxel—ovarian cancer	4.18e-05	0.000526	CcSEcCtD
Trabectedin—Syncope—Epirubicin—ovarian cancer	4.17e-05	0.000525	CcSEcCtD
Trabectedin—Leukopenia—Epirubicin—ovarian cancer	4.16e-05	0.000524	CcSEcCtD
Trabectedin—Back pain—Doxorubicin—ovarian cancer	4.16e-05	0.000524	CcSEcCtD
Trabectedin—Headache—Paclitaxel—ovarian cancer	4.16e-05	0.000523	CcSEcCtD
Trabectedin—Hypersensitivity—Docetaxel—ovarian cancer	4.14e-05	0.000522	CcSEcCtD
Trabectedin—Loss of consciousness—Epirubicin—ovarian cancer	4.08e-05	0.000514	CcSEcCtD
Trabectedin—Cough—Epirubicin—ovarian cancer	4.05e-05	0.000511	CcSEcCtD
Trabectedin—Asthenia—Docetaxel—ovarian cancer	4.03e-05	0.000508	CcSEcCtD
Trabectedin—Anaemia—Doxorubicin—ovarian cancer	3.97e-05	0.000501	CcSEcCtD
Trabectedin—Arthralgia—Epirubicin—ovarian cancer	3.96e-05	0.000498	CcSEcCtD
Trabectedin—Myalgia—Epirubicin—ovarian cancer	3.96e-05	0.000498	CcSEcCtD
Trabectedin—Nausea—Paclitaxel—ovarian cancer	3.94e-05	0.000496	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	3.93e-05	0.000495	CcSEcCtD
Trabectedin—Syncope—Doxorubicin—ovarian cancer	3.86e-05	0.000486	CcSEcCtD
Trabectedin—Leukopenia—Doxorubicin—ovarian cancer	3.85e-05	0.000485	CcSEcCtD
Trabectedin—Diarrhoea—Docetaxel—ovarian cancer	3.85e-05	0.000485	CcSEcCtD
Trabectedin—Oedema—Epirubicin—ovarian cancer	3.79e-05	0.000478	CcSEcCtD
Trabectedin—Loss of consciousness—Doxorubicin—ovarian cancer	3.78e-05	0.000476	CcSEcCtD
Trabectedin—Infection—Epirubicin—ovarian cancer	3.77e-05	0.000475	CcSEcCtD
Trabectedin—Cough—Doxorubicin—ovarian cancer	3.75e-05	0.000473	CcSEcCtD
Trabectedin—Shock—Epirubicin—ovarian cancer	3.73e-05	0.00047	CcSEcCtD
Trabectedin—Nervous system disorder—Epirubicin—ovarian cancer	3.72e-05	0.000468	CcSEcCtD
Trabectedin—Dizziness—Docetaxel—ovarian cancer	3.72e-05	0.000468	CcSEcCtD
Trabectedin—Thrombocytopenia—Epirubicin—ovarian cancer	3.71e-05	0.000468	CcSEcCtD
Trabectedin—Skin disorder—Epirubicin—ovarian cancer	3.68e-05	0.000464	CcSEcCtD
Trabectedin—Myalgia—Doxorubicin—ovarian cancer	3.66e-05	0.000461	CcSEcCtD
Trabectedin—Arthralgia—Doxorubicin—ovarian cancer	3.66e-05	0.000461	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	3.64e-05	0.000458	CcSEcCtD
Trabectedin—Anorexia—Epirubicin—ovarian cancer	3.61e-05	0.000455	CcSEcCtD
Trabectedin—Vomiting—Docetaxel—ovarian cancer	3.57e-05	0.00045	CcSEcCtD
Trabectedin—Rash—Docetaxel—ovarian cancer	3.55e-05	0.000447	CcSEcCtD
Trabectedin—Hypotension—Epirubicin—ovarian cancer	3.54e-05	0.000446	CcSEcCtD
Trabectedin—Dermatitis—Docetaxel—ovarian cancer	3.54e-05	0.000446	CcSEcCtD
Trabectedin—Headache—Docetaxel—ovarian cancer	3.52e-05	0.000444	CcSEcCtD
Trabectedin—Oedema—Doxorubicin—ovarian cancer	3.51e-05	0.000442	CcSEcCtD
Trabectedin—Infection—Doxorubicin—ovarian cancer	3.49e-05	0.000439	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	3.46e-05	0.000435	CcSEcCtD
Trabectedin—Shock—Doxorubicin—ovarian cancer	3.45e-05	0.000435	CcSEcCtD
Trabectedin—Nervous system disorder—Doxorubicin—ovarian cancer	3.44e-05	0.000433	CcSEcCtD
Trabectedin—Thrombocytopenia—Doxorubicin—ovarian cancer	3.44e-05	0.000433	CcSEcCtD
Trabectedin—Insomnia—Epirubicin—ovarian cancer	3.43e-05	0.000432	CcSEcCtD
Trabectedin—Skin disorder—Doxorubicin—ovarian cancer	3.41e-05	0.000429	CcSEcCtD
Trabectedin—Paraesthesia—Epirubicin—ovarian cancer	3.41e-05	0.000429	CcSEcCtD
Trabectedin—Dyspnoea—Epirubicin—ovarian cancer	3.38e-05	0.000426	CcSEcCtD
Trabectedin—Anorexia—Doxorubicin—ovarian cancer	3.34e-05	0.000421	CcSEcCtD
Trabectedin—Nausea—Docetaxel—ovarian cancer	3.34e-05	0.000421	CcSEcCtD
Trabectedin—Dyspepsia—Epirubicin—ovarian cancer	3.34e-05	0.000421	CcSEcCtD
Trabectedin—Decreased appetite—Epirubicin—ovarian cancer	3.3e-05	0.000415	CcSEcCtD
Trabectedin—Hypotension—Doxorubicin—ovarian cancer	3.28e-05	0.000413	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Epirubicin—ovarian cancer	3.27e-05	0.000412	CcSEcCtD
Trabectedin—Fatigue—Epirubicin—ovarian cancer	3.27e-05	0.000412	CcSEcCtD
Trabectedin—Constipation—Epirubicin—ovarian cancer	3.24e-05	0.000409	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	3.2e-05	0.000403	CcSEcCtD
Trabectedin—Insomnia—Doxorubicin—ovarian cancer	3.17e-05	0.0004	CcSEcCtD
Trabectedin—Paraesthesia—Doxorubicin—ovarian cancer	3.15e-05	0.000397	CcSEcCtD
Trabectedin—Dyspnoea—Doxorubicin—ovarian cancer	3.13e-05	0.000394	CcSEcCtD
Trabectedin—Gastrointestinal pain—Epirubicin—ovarian cancer	3.1e-05	0.000391	CcSEcCtD
Trabectedin—Dyspepsia—Doxorubicin—ovarian cancer	3.09e-05	0.000389	CcSEcCtD
Trabectedin—Decreased appetite—Doxorubicin—ovarian cancer	3.05e-05	0.000384	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	3.03e-05	0.000382	CcSEcCtD
Trabectedin—Fatigue—Doxorubicin—ovarian cancer	3.03e-05	0.000381	CcSEcCtD
Trabectedin—Constipation—Doxorubicin—ovarian cancer	3e-05	0.000378	CcSEcCtD
Trabectedin—Abdominal pain—Epirubicin—ovarian cancer	3e-05	0.000378	CcSEcCtD
Trabectedin—Body temperature increased—Epirubicin—ovarian cancer	3e-05	0.000378	CcSEcCtD
Trabectedin—Gastrointestinal pain—Doxorubicin—ovarian cancer	2.87e-05	0.000361	CcSEcCtD
Trabectedin—Hypersensitivity—Epirubicin—ovarian cancer	2.79e-05	0.000352	CcSEcCtD
Trabectedin—Abdominal pain—Doxorubicin—ovarian cancer	2.77e-05	0.000349	CcSEcCtD
Trabectedin—Body temperature increased—Doxorubicin—ovarian cancer	2.77e-05	0.000349	CcSEcCtD
Trabectedin—Asthenia—Epirubicin—ovarian cancer	2.72e-05	0.000343	CcSEcCtD
Trabectedin—Diarrhoea—Epirubicin—ovarian cancer	2.59e-05	0.000327	CcSEcCtD
Trabectedin—Hypersensitivity—Doxorubicin—ovarian cancer	2.59e-05	0.000326	CcSEcCtD
Trabectedin—Asthenia—Doxorubicin—ovarian cancer	2.52e-05	0.000317	CcSEcCtD
Trabectedin—Dizziness—Epirubicin—ovarian cancer	2.51e-05	0.000316	CcSEcCtD
Trabectedin—Vomiting—Epirubicin—ovarian cancer	2.41e-05	0.000304	CcSEcCtD
Trabectedin—Diarrhoea—Doxorubicin—ovarian cancer	2.4e-05	0.000302	CcSEcCtD
Trabectedin—Rash—Epirubicin—ovarian cancer	2.39e-05	0.000301	CcSEcCtD
Trabectedin—Dermatitis—Epirubicin—ovarian cancer	2.39e-05	0.000301	CcSEcCtD
Trabectedin—Headache—Epirubicin—ovarian cancer	2.38e-05	0.000299	CcSEcCtD
Trabectedin—Dizziness—Doxorubicin—ovarian cancer	2.32e-05	0.000292	CcSEcCtD
Trabectedin—Nausea—Epirubicin—ovarian cancer	2.25e-05	0.000284	CcSEcCtD
Trabectedin—Vomiting—Doxorubicin—ovarian cancer	2.23e-05	0.000281	CcSEcCtD
Trabectedin—Rash—Doxorubicin—ovarian cancer	2.21e-05	0.000279	CcSEcCtD
Trabectedin—Dermatitis—Doxorubicin—ovarian cancer	2.21e-05	0.000278	CcSEcCtD
Trabectedin—Headache—Doxorubicin—ovarian cancer	2.2e-05	0.000277	CcSEcCtD
Trabectedin—Nausea—Doxorubicin—ovarian cancer	2.08e-05	0.000263	CcSEcCtD
Trabectedin—SRC—Axon guidance—EGFR—ovarian cancer	7.87e-06	0.000193	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PIK3CB—ovarian cancer	7.85e-06	0.000192	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—BRIP1—ovarian cancer	7.83e-06	0.000192	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PPP1CC—ovarian cancer	7.83e-06	0.000192	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CD—ovarian cancer	7.78e-06	0.00019	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—BRIP1—ovarian cancer	7.76e-06	0.00019	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PPP1CC—ovarian cancer	7.76e-06	0.00019	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—XIAP—ovarian cancer	7.72e-06	0.000189	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—SLC2A1—ovarian cancer	7.67e-06	0.000188	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	7.58e-06	0.000185	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PIK3CA—ovarian cancer	7.55e-06	0.000185	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SMARCA4—ovarian cancer	7.52e-06	0.000184	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.51e-06	0.000184	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—KRAS—ovarian cancer	7.44e-06	0.000182	CbGpPWpGaD
Trabectedin—SRC—Disease—PPP2R1A—ovarian cancer	7.41e-06	0.000181	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—YAP1—ovarian cancer	7.4e-06	0.000181	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CYP1B1—ovarian cancer	7.35e-06	0.00018	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EREG—ovarian cancer	7.34e-06	0.00018	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—IL2—ovarian cancer	7.21e-06	0.000176	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—ERBB2—ovarian cancer	7.16e-06	0.000175	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD8A—ovarian cancer	7.15e-06	0.000175	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CTNNB1—ovarian cancer	7.09e-06	0.000173	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MTOR—ovarian cancer	7.06e-06	0.000173	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PIK3CB—ovarian cancer	7.06e-06	0.000173	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HRAS—ovarian cancer	6.99e-06	0.000171	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MMP9—ovarian cancer	6.95e-06	0.00017	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PGR—ovarian cancer	6.88e-06	0.000168	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ERBB2—ovarian cancer	6.87e-06	0.000168	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—MTOR—ovarian cancer	6.78e-06	0.000166	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CB—ovarian cancer	6.78e-06	0.000166	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—IL6—ovarian cancer	6.69e-06	0.000164	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CDKN1B—ovarian cancer	6.63e-06	0.000162	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PPP2R1A—ovarian cancer	6.52e-06	0.00016	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.49e-06	0.000159	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PARP1—ovarian cancer	6.39e-06	0.000156	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDKN1B—ovarian cancer	6.37e-06	0.000156	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—HRAS—ovarian cancer	6.32e-06	0.000155	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CTNNB1—ovarian cancer	6.26e-06	0.000153	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—VEGFA—ovarian cancer	6.24e-06	0.000153	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.2e-06	0.000152	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—STAT3—ovarian cancer	6.18e-06	0.000151	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—AKT1—ovarian cancer	6.17e-06	0.000151	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NRAS—ovarian cancer	6.17e-06	0.000151	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—VEGFA—ovarian cancer	6.12e-06	0.00015	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PTEN—ovarian cancer	6.1e-06	0.000149	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ABCB1—ovarian cancer	6.06e-06	0.000148	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—IL6—ovarian cancer	6.05e-06	0.000148	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NRAS—ovarian cancer	6.05e-06	0.000148	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—FASN—ovarian cancer	6.03e-06	0.000148	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—TYMS—ovarian cancer	5.95e-06	0.000145	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—SLC5A5—ovarian cancer	5.93e-06	0.000145	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MAPK3—ovarian cancer	5.91e-06	0.000144	CbGpPWpGaD
Trabectedin—SRC—Disease—TERT—ovarian cancer	5.88e-06	0.000144	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PTEN—ovarian cancer	5.86e-06	0.000143	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYTB—ovarian cancer	5.86e-06	0.000143	CbGpPWpGaD
Trabectedin—SRC—Immune System—TLR4—ovarian cancer	5.83e-06	0.000143	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—MAPK3—ovarian cancer	5.79e-06	0.000142	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—SLC2A1—ovarian cancer	5.73e-06	0.00014	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—YAP1—ovarian cancer	5.71e-06	0.00014	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.66e-06	0.000138	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.65e-06	0.000138	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MAPK1—ovarian cancer	5.62e-06	0.000137	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—ovarian cancer	5.62e-06	0.000137	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL6ST—ovarian cancer	5.59e-06	0.000137	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—MAPK1—ovarian cancer	5.51e-06	0.000135	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP1B1—ovarian cancer	5.5e-06	0.000134	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—NRAS—ovarian cancer	5.45e-06	0.000133	CbGpPWpGaD
Trabectedin—SRC—Disease—CAV1—ovarian cancer	5.44e-06	0.000133	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—KRAS—ovarian cancer	5.31e-06	0.00013	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—YAP1—ovarian cancer	5.25e-06	0.000128	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—NRAS—ovarian cancer	5.23e-06	0.000128	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MAPK3—ovarian cancer	5.22e-06	0.000128	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—YAP1—ovarian cancer	5.21e-06	0.000127	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—KRAS—ovarian cancer	5.21e-06	0.000127	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PPP2R1A—ovarian cancer	5.19e-06	0.000127	CbGpPWpGaD
Trabectedin—SRC—Disease—IL6ST—ovarian cancer	5.16e-06	0.000126	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.15e-06	0.000126	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.12e-06	0.000125	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.12e-06	0.000125	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.97e-06	0.000122	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MAPK1—ovarian cancer	4.96e-06	0.000121	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—ovarian cancer	4.96e-06	0.000121	CbGpPWpGaD
Trabectedin—SRC—Disease—APC—ovarian cancer	4.96e-06	0.000121	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDH1—ovarian cancer	4.94e-06	0.000121	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	4.87e-06	0.000119	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CAV1—ovarian cancer	4.79e-06	0.000117	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—PIK3CA—ovarian cancer	4.78e-06	0.000117	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—ovarian cancer	4.76e-06	0.000117	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CD—ovarian cancer	4.72e-06	0.000115	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—KRAS—ovarian cancer	4.69e-06	0.000115	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—FASN—ovarian cancer	4.65e-06	0.000114	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—ovarian cancer	4.63e-06	0.000113	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SLC5A5—ovarian cancer	4.58e-06	0.000112	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.58e-06	0.000112	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.53e-06	0.000111	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ABCB1—ovarian cancer	4.53e-06	0.000111	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—ovarian cancer	4.51e-06	0.00011	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—KRAS—ovarian cancer	4.5e-06	0.00011	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—TYMS—ovarian cancer	4.44e-06	0.000109	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—ovarian cancer	4.43e-06	0.000108	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SLC2A1—ovarian cancer	4.42e-06	0.000108	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CG—ovarian cancer	4.37e-06	0.000107	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CD—ovarian cancer	4.36e-06	0.000107	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.33e-06	0.000106	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—IL6—ovarian cancer	4.32e-06	0.000106	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—PIK3CA—ovarian cancer	4.31e-06	0.000105	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—FASN—ovarian cancer	4.28e-06	0.000105	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—FASN—ovarian cancer	4.24e-06	0.000104	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP1B1—ovarian cancer	4.24e-06	0.000104	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SLC5A5—ovarian cancer	4.21e-06	0.000103	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.17e-06	0.000102	CbGpPWpGaD
Trabectedin—SRC—Immune System—ERBB2—ovarian cancer	4.17e-06	0.000102	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—PIK3CA—ovarian cancer	4.14e-06	0.000101	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TERT—ovarian cancer	4.12e-06	0.000101	CbGpPWpGaD
Trabectedin—SRC—Immune System—MTOR—ovarian cancer	4.11e-06	0.000101	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CB—ovarian cancer	4.11e-06	0.000101	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SLC2A1—ovarian cancer	4.07e-06	9.95e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.03e-06	9.86e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—ovarian cancer	3.98e-06	9.74e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—ovarian cancer	3.98e-06	9.74e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.95e-06	9.66e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—ovarian cancer	3.91e-06	9.56e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP1B1—ovarian cancer	3.9e-06	9.54e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP1B1—ovarian cancer	3.87e-06	9.45e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1B—ovarian cancer	3.86e-06	9.44e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—ERBB2—ovarian cancer	3.85e-06	9.41e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CD—ovarian cancer	3.84e-06	9.39e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—ovarian cancer	3.83e-06	9.36e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IL6—ovarian cancer	3.81e-06	9.33e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CAV1—ovarian cancer	3.81e-06	9.32e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CB—ovarian cancer	3.8e-06	9.29e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MTOR—ovarian cancer	3.8e-06	9.29e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL2—ovarian cancer	3.78e-06	9.24e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	3.76e-06	9.2e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.74e-06	9.15e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ESR1—ovarian cancer	3.67e-06	8.98e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CTNNB1—ovarian cancer	3.65e-06	8.92e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6ST—ovarian cancer	3.61e-06	8.84e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CAV1—ovarian cancer	3.58e-06	8.76e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1B—ovarian cancer	3.57e-06	8.72e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTEN—ovarian cancer	3.56e-06	8.7e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—ovarian cancer	3.52e-06	8.6e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ABCB1—ovarian cancer	3.49e-06	8.54e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CG—ovarian cancer	3.47e-06	8.49e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—APC—ovarian cancer	3.47e-06	8.49e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	3.46e-06	8.46e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—YAP1—ovarian cancer	3.43e-06	8.4e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TYMS—ovarian cancer	3.43e-06	8.39e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.43e-06	8.39e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.41e-06	8.34e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—ovarian cancer	3.38e-06	8.26e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CTNNB1—ovarian cancer	3.37e-06	8.24e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CB—ovarian cancer	3.34e-06	8.18e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PTEN—ovarian cancer	3.28e-06	8.03e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CG—ovarian cancer	3.26e-06	7.98e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ABCB1—ovarian cancer	3.21e-06	7.85e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.18e-06	7.79e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—STAT3—ovarian cancer	3.18e-06	7.78e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—NRAS—ovarian cancer	3.17e-06	7.76e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TYMS—ovarian cancer	3.15e-06	7.71e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TYMS—ovarian cancer	3.13e-06	7.65e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CD—ovarian cancer	3.05e-06	7.46e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAPK3—ovarian cancer	3.04e-06	7.43e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—STAT3—ovarian cancer	2.94e-06	7.18e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—NRAS—ovarian cancer	2.93e-06	7.16e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAPK1—ovarian cancer	2.89e-06	7.07e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTEN—ovarian cancer	2.89e-06	7.07e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—ovarian cancer	2.89e-06	7.07e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CD—ovarian cancer	2.87e-06	7.01e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MAPK3—ovarian cancer	2.8e-06	6.86e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—FASN—ovarian cancer	2.8e-06	6.85e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CAV1—ovarian cancer	2.76e-06	6.76e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.75e-06	6.73e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—ovarian cancer	2.73e-06	6.68e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—ovarian cancer	2.73e-06	6.67e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ERBB2—ovarian cancer	2.7e-06	6.59e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MAPK1—ovarian cancer	2.67e-06	6.53e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—ovarian cancer	2.67e-06	6.53e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MTOR—ovarian cancer	2.66e-06	6.51e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CB—ovarian cancer	2.66e-06	6.51e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.66e-06	6.5e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.64e-06	6.46e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL8—ovarian cancer	2.56e-06	6.25e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.55e-06	6.24e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CAV1—ovarian cancer	2.54e-06	6.22e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—ovarian cancer	2.52e-06	6.16e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CAV1—ovarian cancer	2.52e-06	6.16e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.52e-06	6.16e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CA—ovarian cancer	2.51e-06	6.13e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CB—ovarian cancer	2.5e-06	6.11e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1B—ovarian cancer	2.5e-06	6.11e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CASP3—ovarian cancer	2.45e-06	5.98e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL2—ovarian cancer	2.44e-06	5.98e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.41e-06	5.89e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—ovarian cancer	2.38e-06	5.82e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CTNNB1—ovarian cancer	2.36e-06	5.77e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—ovarian cancer	2.32e-06	5.68e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CA—ovarian cancer	2.32e-06	5.66e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.31e-06	5.66e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MMP9—ovarian cancer	2.31e-06	5.66e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTEN—ovarian cancer	2.3e-06	5.62e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.29e-06	5.61e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.26e-06	5.53e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL6—ovarian cancer	2.22e-06	5.43e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.21e-06	5.41e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTEN—ovarian cancer	2.16e-06	5.28e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—ovarian cancer	2.14e-06	5.24e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.1e-06	5.13e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—ovarian cancer	2.08e-06	5.08e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TYMS—ovarian cancer	2.06e-06	5.04e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STAT3—ovarian cancer	2.06e-06	5.03e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NRAS—ovarian cancer	2.05e-06	5.02e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—IL6—ovarian cancer	2.05e-06	5.02e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—ovarian cancer	2.05e-06	5.01e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CA—ovarian cancer	2.04e-06	4.99e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.03e-06	4.98e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.02e-06	4.93e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK3—ovarian cancer	1.96e-06	4.8e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.93e-06	4.72e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—ovarian cancer	1.91e-06	4.67e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—ovarian cancer	1.89e-06	4.63e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK1—ovarian cancer	1.87e-06	4.57e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—ovarian cancer	1.87e-06	4.57e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.77e-06	4.34e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—ovarian cancer	1.77e-06	4.32e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.76e-06	4.3e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTEN—ovarian cancer	1.67e-06	4.08e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—ovarian cancer	1.67e-06	4.07e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CAV1—ovarian cancer	1.66e-06	4.06e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CA—ovarian cancer	1.62e-06	3.97e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—ovarian cancer	1.57e-06	3.84e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTEN—ovarian cancer	1.53e-06	3.75e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.52e-06	3.73e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTEN—ovarian cancer	1.52e-06	3.72e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.51e-06	3.7e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—ovarian cancer	1.5e-06	3.67e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6—ovarian cancer	1.44e-06	3.51e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.33e-06	3.25e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—ovarian cancer	1.32e-06	3.24e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—ovarian cancer	1.24e-06	3.04e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.18e-06	2.88e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.16e-06	2.84e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.08e-06	2.64e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.07e-06	2.62e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTEN—ovarian cancer	1e-06	2.45e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—ovarian cancer	9.6e-07	2.35e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—ovarian cancer	8.83e-07	2.16e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—ovarian cancer	8.76e-07	2.14e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CA—ovarian cancer	7.07e-07	1.73e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—ovarian cancer	5.78e-07	1.41e-05	CbGpPWpGaD
